Tirzepatide (Mounjaro, Zepbound) works as a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
This is where medical weight loss solutions, like compounded semaglutide, make a profound difference
10.3390/md22020076 75
Chest pain, shortness of breath, or rapid heart rate : which could indicate cardiovascular complications Severe weakness or inability to perform normal activities : suggesting possible electrolyte imbalances or other serious conditions You should also schedule a non-urgent appointment if you notice unintentional excessive weight loss (more than 23 pounds per week consistently), difficulty maintaining adequate nutrition , or new symptoms such as cold intolerance, hair loss, or mood changes that might suggest thyroid dysfunction or other endocrine issues
Potential secondary peaks may represent deletion sequences, truncated material, incompletely lipidated peptide, oxidized species or other degradation products
